Abstract
An oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus evolved and emerged from zero to 52% of detectable virus within 48 hours of a patient's exposure to oseltamivir. Phylogenetic analysis and data gathered by pyrosequencing and cloning directly on clinical samples suggest that the mutant emerged de novo.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antiviral Agents / pharmacology*
-
Drug Resistance, Viral / genetics*
-
Evolution, Molecular
-
Female
-
Humans
-
Influenza A Virus, H1N1 Subtype / drug effects*
-
Influenza A Virus, H1N1 Subtype / genetics
-
Influenza A Virus, H1N1 Subtype / isolation & purification
-
Influenza A Virus, H1N1 Subtype / pathogenicity
-
Influenza, Human / drug therapy*
-
Influenza, Human / epidemiology
-
Influenza, Human / virology
-
Mutation*
-
Oseltamivir / pharmacology*
-
Pandemics
-
Phylogeny
-
Sequence Analysis, DNA / methods
-
Time Factors
Substances
-
Antiviral Agents
-
Oseltamivir